These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2119437)

  • 41. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx.
    Esteban F; Ruiz-Cabello F; Concha A; Perez Ayala M; Delgado M; Garrido F
    Cancer; 1990 Oct; 66(7):1493-8. PubMed ID: 2208000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
    Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
    Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography.
    Stack BC; Dalsaso TA; Lee C; Lowe VJ; Hamilton PD; Fletcher JW; Fernandez-Pol JA
    Anticancer Res; 1999; 19(6C):5503-10. PubMed ID: 10697607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
    Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma.
    Salter ER; Tichansky D; Furth EE; Herlyn AM
    In Vitro Cell Dev Biol Anim; 2001 Sep; 37(8):530-5. PubMed ID: 11669287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
    Koch T; Eiffert H; Spindler MB
    HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
    Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region.
    Haines GK; Becker S; Ghadge G; Kies M; Pelzer H; Radosevich JA
    Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1142-7. PubMed ID: 8104427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
    Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
    BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Squamous cell carcinoma-antigen for detection of squamous cell and mucoepidermoid carcinoma after primary treatment: a preliminary report.
    Yoshimura Y; Oka M; Harada T
    J Oral Maxillofac Surg; 1990 Dec; 48(12):1288-92; discussion 1292-3. PubMed ID: 2231147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncofetal antigen expression in head and neck carcinoma.
    Gussack GS
    Laryngoscope; 1992 Feb; 102(2):168-76. PubMed ID: 1738289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.
    Mino N; Iio A; Hamamoto K
    Cancer; 1988 Aug; 62(4):730-4. PubMed ID: 2840187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Squamous cell carcinoma radioimmunoassay in squamous cell carcinoma of the head and neck.
    Cook DW; Winek T; Baker H; Deveney CW; Sasaki T
    Am J Surg; 1989 May; 157(5):503-4. PubMed ID: 2712209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
    Miyake M; Taki T; Hitomi S; Hakomori S
    N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
    Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
    J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.